https://www.selleckchem.com/pr....oducts/liraglutide.h
Solid phase binding assays were used to evaluate the effectivity of heparin(oids) and recombinant Salp20 to block the pattern recognition of properdin. Results Binding of serum-derived and recombinant properdin preparations to PTECs could be dose-dependently inhibited (P C3b. Discussion In this study we showed that all properdin preparations recognize heparan sulfate/syndecan-1 on PTECs with and without Compstatin C3 blocking conditions. In contrast to Compstatin, recombinant Salp20 prevents heparan sulfate pattern recognition by pr
Like
Comment
Share
